CD44 and prostate cancer: In this study, we observed that FKA treatment decreased both the size and numbers of the tumor spheroids growing from CD44+/CD133+ tumor stem cells, which were sorted out by flow cytometry sorting (FACS) from the bulk cultures of prostate cancer DU145 and 22Rv1 cells.